88636 Federal Register / Vol. 88, No. 245 / Friday, December 22, 2023 / Notices 

The OMB control number and 

expiration date of OMB approval for 

each information collection are shown 

in table 1. Copies of the supporting 

statements for the information 

collections are available on the internet 

at https://www.reginfo.gov/public/do/ 

PRAMain. An Agency may not conduct 

or sponsor, and a person is not required 

to respond to, a collection of 

information unless it displays a 

currently valid OMB control number. 

TABLE 1.—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB 

Title of collection OMB control 

No. 

Date approval 

expires 

Generic Clearance for Qualitative Data to Support Social and Behavioral Research for Food, Dietary Supplements, Cosmetics, and Animal Food and Feed .................................................................................................. 0910–0891 9/30/2026 

Medical Devices—Voluntary Improvement Program ............................................................................................... 0910–0922 9/30/2026 

Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a 

Master File in Support of Petitions, and Electronic Submission Using FDA Form 3503 .................................... 0910–0016 10/31/2026 

Infant Formula Requirements .................................................................................................................................. 0910–0256 10/31/2026 

Biologics License Applications; Procedures & Requirements ................................................................................. 0910–0338 10/31/2026 

Medical Devices; Reports of Corrections and Removals ........................................................................................ 0910–0359 10/31/2026 

Customer/Partner Satisfaction Service Surveys ..................................................................................................... 0910–0360 10/31/2026 

Voluntary National Retail Food Regulatory Program Standards ............................................................................ 0910–0621 10/31/2026 

Expanded Access to Investigational Drugs for Treatment Use .............................................................................. 0910–0814 10/31/2026 

Food Canning Establishment Registration, Process Filing and Recordkeeping for Acidified and Thermally Processed Low-Acid Foods ......................................................................................................................................... 0910–0037 11/30/2026 

Color Additive Certification ...................................................................................................................................... 0910–0216 11/30/2026 

Reporting and Recordkeeping Requirements for Reportable Food ........................................................................ 0910–0643 11/30/2026 

Prescription Drug Advertisements; Presentation of Advertisements in Television and Radio ............................... 0910–0686 11/30/2026 

Submission to CDRH Allegations of Regulatory Misconduct Associated with Medical Devices ............................ 0910–0769 11/30/2026 

Importation of Prescription Drugs ............................................................................................................................ 0910–0888 11/30/2026 

Dated: December 19, 2023. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2023–28290 Filed 12–21–23; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–0990–new] 

Agency Father Generic Information 

Collection Request; 60-Day Public 

Comment Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment, 

Improving Customer Experience (OMB 

Circular A–11, Section 280 

Implementation). 

DATES: Comments on the ICR must be 

received on or before February 20, 2024. 

ADDRESSES: Submit your comments to 

Sherrette.Funn@hhs.gov or by calling 

(202) 264–0041 and PRA@HHS.GOV. 

FOR FURTHER INFORMATION CONTACT: 

When submitting comments or 

requesting information, please include 

the document identifier 0990-New-60D 

and project title for reference, to 

Sherrette A. Funn, email: 

Sherrette.Funn@hhs.gov, PRA@

HHS.GOV or call (202) 264–0041 the 

Reports Clearance Officer. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: Improving 

Customer Experience (OMB Circular A– 

11, Section 280. 

Type of Collection: Father Generic 

ICR. 

OMB No.: 0990–XXXX, Office within 

Office of the Secretary, Assistant 

Secretary Administration. 

Abstract: The Department of Health 

and Human Services, Office of the 

Secretary, Assistant Secretary 

Administration is requesting approval 

by OMB on a new Father Generic 

Information Collection Request. OMB 

Circular A–11 Section 280 established 

government-wide standards for mature 

customer experience organizations in 

government and measurement. To 

enable Federal programs to deliver the 

experience taxpayers deserve, they must 

undertake three general categories of 

activities: conduct ongoing customer 

research, gather and share customer 

feedback, and test services and digital 

products. 

These data collection efforts may be 

either qualitative or quantitative in 

nature or may consist of mixed 

methods. Additionally, data may be 

collected via a variety of means, 

including but not limited to electronic 

or social media, direct or indirect 

observation (i.e., in person, video and 

audio collections), interviews, 

questionnaires, surveys, and focus 

groups. HHS will limit its inquiries to 

data collections that solicit strictly 

voluntary opinions or responses. Steps 

will be taken to ensure anonymity of 

respondents in each activity covered by 

this request. 

The results of the data collected will 

be used to improve the delivery of 

Federal services and programs. It will 

include the creation of personas, 

customer journey maps, and reports and 

summaries of customer feedback data 

and user insights. It will also provide 

government-wide data on customer 

experience that can be displayed on 

performance.gov to help build 

transparency and accountability of 

Federal programs to the customers they 

serve. 

Implementation). 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 245 / Friday, December 22, 2023 / Notices 88637 

ANNUALIZED BURDEN HOUR TABLE

Respondents 

(if necessary) 

Number of 

respondents 

Number of 

responses per 

respondents 

Average 

burden hours 

per response 

Total burden 

hours 

Participants in customer interviews ................................................................. 500 1 1 500 

Participants in focus groups ............................................................................ 450 1 90/60 675 

Participants of feedback surveys ..................................................................... 2,000,000 1 3/60 100,000 

Participants in user testing (rapid) ................................................................... 400 1 15/60 100 

Participants in user testing (deep dive) ........................................................... 200 1 30/60 100 

Total .......................................................................................................... 2,001,550 ........................ ........................ 101,375 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2023–28283 Filed 12–21–23; 8:45 am] 

BILLING CODE 4150–04–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Notice and Request for Comments on 

the Implications of Access and Benefit 

Sharing (ABS) Commitments/Regimes 

and Other Proposed Commitments 

Being Considered Under a WHO 

Convention, Agreement or Other 

International Instrument on Pandemic 

Prevention, Preparedness and 

Response 

AGENCY: Office for Global Affairs, Office 

of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: This Request for Comment 

seeks information from stakeholders, 

broadly defined, on concepts currently 

under consideration by parties 

negotiating a World Health Organization 

(WHO) Pandemic Preparedness 

Agreement. It seeks information on how 

stakeholders’ efforts to facilitate 

response efforts, including the rapid 

creation and equitable deployment of 

safe and effective vaccines, diagnostic 

tests, and treatments, can be advanced 

or hindered by concepts and 

commitments under consideration by 

the negotiating parties as reflected in 

current negotiating text. 

DATES: To be assured consideration, 

written comments must be received by 

5 p.m. Eastern time on January 22, 2024. 

Written comments should be emailed to 

OGA.RSVP@hhs.gov with the subject 

line ‘‘Written Comment Re: Implications 

of Access and Benefit Sharing (ABS) 

Commitments/Regimes and Other 

Proposed Commitments in the WHO 

Pandemic Agreement’’ by January 22, 

2024. Comments received after that date 

will be considered to the extent 

practicable. 

The Department’s policy is to make 

all comments received from members of 

the public available for public viewing 

on the Federal eRulemaking Portal at 

www.regulations.gov. In this instance, 

business confidential submissions will 

also be accepted. Note that relevant 

comments submitted to regulations.gov 

will be posted without editing and will 

be available to the public; therefore, 

business-confidential information 

should be clearly identified as such and 

an accompanying redacted version 

should be submitted for posting on 

regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Susan Kim, Office for Global Affairs, 

Office of the Secretary, HHS, Room 

(639H) Hubert H. Humphrey Building, 

200 Independence Avenue SW, 

Washington, DC 20201, (202) 235–3537. 

SUPPLEMENTARY INFORMATION: 

Background: In December 2021, 

WHO’s Member States decided at a 

Special Session of the World Health 

Assembly to establish an 

intergovernmental negotiating body 

(INB), representing all regions of the 

world, to draft and negotiate a WHO 

convention, agreement, or other 

international instrument on pandemic 

prevention, preparedness, and response. 

More information about the INB process 

can be found here: https://inb.who.int/ 

home/inb-process. The INB currently 

intends to submit its outcome to the 

Seventy-seventh World Health 

Assembly in May 2024. 

The United States has expressed 

support for the development of an 

international instrument to protect the 

world from pandemic health threats 

now and in the future, and in a more 

rapid and equitable manner. 

The United States is seeking the 

following key outcomes in the 

negotiations: 

• Enhance the capacity of countries 

around the world to prevent, prepare 

for, and respond to pandemic 

emergencies and provide clear, credible, 

consistent information to their citizens. 

• Ensure that all countries share data 

and laboratory samples from emerging 

outbreaks quickly, safely, and 

transparently to facilitate response 

efforts and inform public health 

decision making regarding effective 

disease control measures, including the 

rapid creation of safe and effective 

vaccines, diagnostic tests, and 

treatments. 

• Support more equitable and timely 

access to, and delivery of, vaccines, 

diagnostic tests, treatments, and other 

mitigation measures to quickly contain 

outbreaks, reduce illness and death, and 

minimize impacts on the economic and 

national security of people around the 

world. 

Purpose: The U.S. Department of 

Health and Human Services (HHS) and 

the Department of State are charged 

with co-leading the U.S. delegation to 

the Intergovernmental Negotiating Body 

(INB) to draft and negotiate a WHO 

convention, agreement or other 

international instrument on pandemic 

prevention, preparedness, and response. 

This Request for Comments procedure 

is designed to seek input from 

stakeholders and subject matter experts 

to help inform the U.S. government 

negotiating position, including new 

approaches, proposals, or concerns with 

the current version of the negotiating 

text. 

The most recent Negotiating Text of 

the WHO Pandemic Agreement 

(Negotiating Text) can be found here: 

https://apps.who.int/gb/inb/pdf_files/ 

inb7/A_INB7_3-en.pdf. 

Representatives from HHS, State and 

the Department of Commerce will 

review written submissions and share 

them, as appropriate, with staff from 

other Federal Agencies to inform U.S. 

Government policy and our 

international engagements on these 

issues. U.S. officials may contact 

individuals making submissions for 

further information or explanation. 

Respondent information. Please note 

the following information is not 

required but will assist us in 

contextualizing responses. If possible, in 

your submission, please include 

institution or organization name and 

type; for foreign-based entities, please 


ddrumheller on DSK120RN23PROD with NOTICES1